Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account

<p>Introduction: Changes in urinary albumin-to-creatinine ratio (UACR) may affect the risk of advanced chronic kidney disease (CKD). How much the effect depends upon natural variation and the time period for the change is unknown.</p><p> Methods: English Clinical Practice Research...

Celý popis

Podrobná bibliografie
Hlavní autoři: Smith, M, Herrington, WG, Weldegiorgis, M, Hobbs, FDR, Bankhead, C, Woodward, M
Médium: Journal article
Vydáno: Elsevier 2018
_version_ 1826290686070095872
author Smith, M
Herrington, WG
Weldegiorgis, M
Hobbs, FDR
Bankhead, C
Woodward, M
author_facet Smith, M
Herrington, WG
Weldegiorgis, M
Hobbs, FDR
Bankhead, C
Woodward, M
author_sort Smith, M
collection OXFORD
description <p>Introduction: Changes in urinary albumin-to-creatinine ratio (UACR) may affect the risk of advanced chronic kidney disease (CKD). How much the effect depends upon natural variation and the time period for the change is unknown.</p><p> Methods: English Clinical Practice Research Datalink records (2000-2015), with linkage to secondary care and death certification, were used to identify prospective cohorts with at least two measures of UACR within 1, 2 and 3 years. Adjusted Cox regression assessed the separate relevance of baseline UACR and UACR change to the risk of developing CKD stage 4-5 and end-stage renal disease (ESRD). Associations were compared before and after accounting for the effects of natural regression to the mean (RtM).</p><p> Results: 212,810 individuals had baseline UACR measurements; 22% had a UACR ≥3.4, and 3% had UACR ≥33.9, mg/mmol. During a median 4.0 years follow-up, 5976 developed CKD stage 4-5 and 1076 developed ESRD. There were strong associations between baseline UACR and CKD stage 4-5 or ESRD risk, which doubled in strength after accounting for RtM. Over 3 years, the hazard ratios, HRs (95%CIs) for CKD stage 4-5, relative to stable UACR, were 0.62 (0.50-0.77) for at least a halving of UACR and 2.68 (2.29-3.14) for at least a doubling. Associations were weaker for shorter exposure windows (and for cardiovascular disease or death), but strengthened after allowing for RtM.</p><p> Conclusion: Baseline values and medium term increases in albuminuria are both associated with substantially increased risk of developing advanced CKD. Standard analyses, not allowing for RtM, may underestimate these associations.</p>
first_indexed 2024-03-07T02:47:59Z
format Journal article
id oxford-uuid:acabd926-db19-43be-bb99-a6bcd0fb48c5
institution University of Oxford
last_indexed 2024-03-07T02:47:59Z
publishDate 2018
publisher Elsevier
record_format dspace
spelling oxford-uuid:acabd926-db19-43be-bb99-a6bcd0fb48c52022-03-27T03:30:38ZChange in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into accountJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:acabd926-db19-43be-bb99-a6bcd0fb48c5Symplectic Elements at OxfordElsevier2018Smith, MHerrington, WGWeldegiorgis, MHobbs, FDRBankhead, CWoodward, M<p>Introduction: Changes in urinary albumin-to-creatinine ratio (UACR) may affect the risk of advanced chronic kidney disease (CKD). How much the effect depends upon natural variation and the time period for the change is unknown.</p><p> Methods: English Clinical Practice Research Datalink records (2000-2015), with linkage to secondary care and death certification, were used to identify prospective cohorts with at least two measures of UACR within 1, 2 and 3 years. Adjusted Cox regression assessed the separate relevance of baseline UACR and UACR change to the risk of developing CKD stage 4-5 and end-stage renal disease (ESRD). Associations were compared before and after accounting for the effects of natural regression to the mean (RtM).</p><p> Results: 212,810 individuals had baseline UACR measurements; 22% had a UACR ≥3.4, and 3% had UACR ≥33.9, mg/mmol. During a median 4.0 years follow-up, 5976 developed CKD stage 4-5 and 1076 developed ESRD. There were strong associations between baseline UACR and CKD stage 4-5 or ESRD risk, which doubled in strength after accounting for RtM. Over 3 years, the hazard ratios, HRs (95%CIs) for CKD stage 4-5, relative to stable UACR, were 0.62 (0.50-0.77) for at least a halving of UACR and 2.68 (2.29-3.14) for at least a doubling. Associations were weaker for shorter exposure windows (and for cardiovascular disease or death), but strengthened after allowing for RtM.</p><p> Conclusion: Baseline values and medium term increases in albuminuria are both associated with substantially increased risk of developing advanced CKD. Standard analyses, not allowing for RtM, may underestimate these associations.</p>
spellingShingle Smith, M
Herrington, WG
Weldegiorgis, M
Hobbs, FDR
Bankhead, C
Woodward, M
Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title_full Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title_fullStr Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title_full_unstemmed Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title_short Change in albuminuria and risk of renal and cardiovascular outcomes: natural variation should be taken into account
title_sort change in albuminuria and risk of renal and cardiovascular outcomes natural variation should be taken into account
work_keys_str_mv AT smithm changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount
AT herringtonwg changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount
AT weldegiorgism changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount
AT hobbsfdr changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount
AT bankheadc changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount
AT woodwardm changeinalbuminuriaandriskofrenalandcardiovascularoutcomesnaturalvariationshouldbetakenintoaccount